Hawryluk P. Kent

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 59% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 176%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Hawryluk P. Kent's trades of MBX Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
424.61
Quantity 94,801
Value US$716,160
Transaction date
Proposed sale
Price
459.14
Quantity 47,743
Value US$3,121,300
Transaction date
Sale
Price
398.15
Quantity 62,657 +26.0%
Value US$4,006,305
Transaction date
Proposed sale
Price
29.54
Quantity 607
Value US$17,934
Transaction date
Purchase
Price
28.41
Quantity 18,500 +4.0%
Value US$525,663
Transaction date
Purchase
Price
13.64
Quantity 20,000 +4.5%
Value US$272,790
Transaction date
Purchase
Price
10.69
Quantity 50,000 +12.6%
Value US$534,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-17
PrS Proposed sale
94,801
424.61
US$716,160 		94,801 424.61 US$716,160
2026-08-04 2026-08-04
PrS Proposed sale
47,743
459.14
US$3,121,300 		47,743 459.14 US$3,121,300
2026-05-08 2026-05-06
S Sale
62,657 +26.0%
398.15
US$4,006,305 		62,657 +26.0% 398.15 US$4,006,305
2026-05-06 2026-05-06
PrS Proposed sale
607
29.54
US$17,934 		607 29.54 US$17,934
2026-03-16 2026-03-13
B Purchase
18,500 +4.0%
28.41
US$525,663 		18,500 +4.0% 28.41 US$525,663
2025-10-21 2025-10-20
B Purchase
20,000 +4.5%
13.64
US$272,790 		20,000 +4.5% 13.64 US$272,790
2025-02-05 2025-02-04
B Purchase
50,000 +12.6%
10.69
US$534,500 		50,000 +12.6% 10.69 US$534,500